Article ID Journal Published Year Pages File Type
5536971 Vaccine 2017 11 Pages PDF
Abstract
We conclude that the VE of commercial vaccines in Indonesia changes as Indonesian HPAI/H5N1 evolve into new clades, which should warrant continuous matching between vaccine-seeds and emerging HPAI/H5N1. Furthermore, given the characteristics of the new Indonesian dominant HPAI/H5N1 clade, further studies to confirm VE across species are warranted.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
Vaccine efficacy against Indonesian Highly Pathogenic Avian Influenza H5N1: systematic review and meta-analysis
Authors
, , , ,